Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis: A Phase 2 Randomized Clinical Trial von Gooderham, Melinda J, Forman, Seth B, Bissonnette, Robert, Beebe, Jean S, Zhang, Weidong, Banfield, Chris, Zhu, Linda, Papacharalambous, Jocelyne, Vincent, Michael S, Peeva, Elena

Volltext

Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study von Guttman-Yassky, Emma, Silverberg, Jonathan I., Nemoto, Osamu, Forman, Seth B., Wilke, August, Prescilla, Randy, de la Peña, Amparo, Nunes, Fabio P., Janes, Jonathan, Gamalo, Margaret, Donley, David, Paik, Jim, DeLozier, Amy M., Nickoloff, Brian J., Simpson, Eric L.

Volltext

Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies von Papp, Kim, Szepietowski, Jacek C., Kircik, Leon, Toth, Darryl, Eichenfield, Lawrence F., Leung, Donald Y.M., Forman, Seth B., Venturanza, May E., Sun, Kang, Kuligowski, Michael E., Simpson, Eric L.

Volltext

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa von Kimball, Alexa B, Okun, Martin M, Williams, David A, Gottlieb, Alice B, Papp, Kim A, Zouboulis, Christos C, Armstrong, April W, Kerdel, Francisco, Gold, Michael H, Forman, Seth B, Korman, Neil J, Giamarellos-Bourboulis, Evangelos J, Crowley, Jeffrey J, Lynde, Charles, Reguiai, Ziad, Prens, Errol-Prospero, Alwawi, Eihab, Mostafa, Nael M, Pinsky, Brett, Sundaram, Murali, Gu, Yihua, Carlson, Dawn M, Jemec, Gregor B.E

Volltext

TYK2/JAK1 Inhibitor PF-06700841 in Patients with Plaque Psoriasis: Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial von Forman, Seth B., Pariser, David M., Poulin, Yves, Vincent, Michael S., Gilbert, Steven A., Kieras, Elizabeth M., Qiu, Ruolun, Yu, Dahong, Papacharalambous, Jocelyne, Tehlirian, Christopher, Peeva, Elena

Volltext

Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies von Papp, Kim, Szepietowski, Jacek C., Kircik, Leon, Toth, Darryl, Eichenfield, Lawrence F., Forman, Seth B., Kuligowski, Michael E., Kallender, Howard, Sun, Kang, Ren, Haobo, Simpson, Eric L.

Volltext

Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial von Blauvelt, Andrew, Draelos, Zoe D., Stein Gold, Linda, Alonso-Llamazares, Javier, Bhatia, Neal, DuBois, Janet, Forman, Seth B., Gooderham, Melinda, Green, Lawrence, Guenthner, Scott T., Hebert, Adelaide A., Lain, Edward, Moore, Angela Y., Papp, Kim A., Zirwas, Matthew, Kato, Saori, Snyder, Scott, Krupa, David, Burnett, Patrick, Berk, David R., Chu, David H.

Volltext

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial von Zirwas, Matthew J, Draelos, Zoe D, DuBois, Janet, Kircik, Leon H, Moore, Angela Y, Stein Gold, Linda, Alonso-Llamazares, Javier, Bukhalo, Michael, Bruce, Suzanne, Eads, Kimmie, Green, Lawrence J, Guenthner, Scott T, Ferris, Laura K, Forman, Seth B, Kempers, Steven E, Lain, Edward, Lynde, Charles W, Pariser, David M, Toth, Darryl P, Yamauchi, Paul S, Higham, Robert C, Krupa, David, Burnett, Patrick, Berk, David R

Volltext

Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical Trials von Simpson, Eric L, Eichenfield, Lawrence F, Alonso-Llamazares, Javier, Draelos, Zoe D, Ferris, Laura K, Forman, Seth B, Gooderham, Melinda, Gonzalez, Mercedes E, Hebert, Adelaide A, Kircik, Leon H, Lomaga, Mark, Moore, Angela, Papp, Kim A, Prajapati, Vimal H, Hanna, Diane, Snyder, Scott, Krupa, David, Burnett, Patrick, Almaraz, Erin, Higham, Robert C, Chu, David H, Berk, David R

Volltext

Insights into adult atopic dermatitis heterogeneity derived from circulating biomarker profiling in patients with moderate‐to‐severe disease von Sims, Jonathan T., Chang, Ching‐Yun, Higgs, Richard E., Engle, Sarah M., Liu, Yushi, Sissons, Sean E., Rodgers, George H., Simpson, Eric L., Silverberg, Jonathan I., Forman, Seth B., Janes, Jonathan M., Colvin, Stephanie C., Guttman‐Yassky, Emma

Volltext

Quantification of melanocytes in sun-damaged skin von Madden, Katherine, BA, Forman, Seth B., MD, Elston, Dirk, MD

Volltext

Is superficial spreading melanoma still the most common form of malignant melanoma? von Forman, Seth B., MD, Ferringer, Tammie C., MD, Peckham, Steven J., MD, USAF, MC, FS, Dalton, Scott R., MD, MC, USA, Sasaki, Geoff T., MD, USAF, MC, FS, Libow, Lester F., MD, Elston, Dirk M., MD

Volltext

Check your skin: Insights regarding skin cancer education von Gillen, William, Forman, Seth B., MD, Nunley, Julia R., MD, Bhole, Sonya, Eliason, Kyle, Fox, Paige, McCall, Calvin O., MD

Volltext

Basal cell carcinoma of the nail unit von Forman, Seth B., MD, Ferringer, Tammie C., MD, Garrett, Algin B., MD

Volltext

Clear-cell basal cell carcinoma : Differentiation from other clear-cell tumors von FORMAN, Seth B, FERRINGER, Tammie C

Volltext

Collision tumor composed of Merkel cell carcinoma and lentigo maligna melanoma von Forman, Seth B., Vidmar, Dennis A., Ferringer, Tammie C.

Volltext

S100 A6 immunohistochemical staining for spindle cell and desmoplastic melanomas von Puri, Puja Kumari, Forman, Seth B., Ferringer, Tammie, Elston, Dirk

Volltext

Penile Granuloma Annulare of an Adolescent Male-Case Report and Review of the Literature von FORMAN, SETH B., SUMFEST, JOEL M., PRIDE, HOWARD B., FERRINGER, TAMMIE C.

Volltext

The significance of melanoma subsets von Libow, Lester F., MD, Forman, Seth B., MD, Ferringer, Tammie C., MD, Peckham, Steven J., MAJ, USAF, MC, FS, Dalton, Scott R., MAJ, MD, MC, USA, Sasaki, Geoff T., MAJ, MD, USAF, MC, FS, Elston, Dirk M., MD

Volltext

Success of omalizumab as monotherapy in adult atopic dermatitis: case report and discussion of the high-affinity immunoglobulin E receptor, FcepsilonRI von Forman, Seth B, Garrett, Algin B

Volltext